Real-World Safety Profile of Proton Pump Inhibitors in Infants as Reported in the FDA Adverse Event Reporting System (FAERS): Tiny Tummies, Key Decisions

<b>Background</b>: Proton pump inhibitors (PPIs) are widely used for gastric acid suppression, yet their efficacy and safety in neonates and infants remain unclear. While esomeprazole is the only Food and Drug Administration (FDA)-approved PPI for neonates and infants under 1 year of age...

Full description

Bibliographic Details

Published in:	Pharmaceuticals
Main Authors:	Hülya Tezel Yalçın, Nadir Yalçın, Karel Allegaert
Format:	Article
Language:	English
Published:	MDPI AG 2025-05-01
Subjects:	drug safety adverse drug event medication error neonates infants acid reducers
Online Access:	https://www.mdpi.com/1424-8247/18/5/730